Gender and Neural Substrates of Stress and Craving
Tracking Information | |
---|---|
First Received Date ICMJE | September 18, 2008 |
Last Updated Date | August 4, 2011 |
Start Date ICMJE | February 2009 |
Primary Completion Date | January 2011 (final data collection date for primary outcome measure) |
Current Primary Outcome Measures ICMJE | |
Original Primary Outcome Measures ICMJE | |
Change History | Complete list of historical versions of study NCT00756925 on ClinicalTrials.gov Archive Site |
Current Secondary Outcome Measures ICMJE | |
Original Secondary Outcome Measures ICMJE | |
Current Other Outcome Measures ICMJE | |
Original Other Outcome Measures ICMJE | |
Descriptive Information | |
Brief Title ICMJE | Gender and Neural Substrates of Stress and Craving |
Official Title ICMJE | Exploring Gender Differences in the Neural Substrates of Stress Induced Drug Craving |
Brief Summary | Cocaine dependence is an insidious disease underscored by a powerful proclivity to relapse despite an individual's ability to recognize the deleterious consequences of continued drug use. To date, there are only a limited number of treatments, and no FDA approved medications for the treatment of cocaine dependence. Attempts to find reliable and successful treatments for cocaine dependence may be marred by gender differences in brain chemistry, structure, and function that are manifested as drug craving and relapse. For example, cues, drug exposure, and stress promote relapse, yet females appear be more susceptible to stress induced relapse, while males may be more susceptible to cue induced relapse. Therefore identifying the neural substrates involved in processing the valence of internal and external stimuli may provide further insight into cocaine dependence and provide more effective therapeutic strategies aimed at preventing relapse. Corticotropin releasing hormone (CRH) is a pharmacological activator of the hypothalamic pituitary adrenal (HPA) axis, and has been implicated in stress induced drug relapse. Corticotropin releasing hormone receptors are located at extrahypothalamic brain nuclei that have been implicated in determining the significance of both internal (somatic) and external (environmental) stimuli. The primary directive of this pilot project is to utilize functional magnetic resonance imaging (fMRI) to identify possible brain nuclei associated with with stress induced drug craving in cocaine dependent females. |
Detailed Description | |
Study Type ICMJE | Observational |
Study Design ICMJE | Observational Model: Case Control Time Perspective: Prospective |
Biospecimen | |
Sampling Method | Non-Probability Sample |
Study Population | A total of 20 cocaine dependent subjects (10 cocaine dependent females and 10 cocaine dependent males) will be enrolled in the study. Inclusion/exclusion criteria are listed in Section E, Human Subjects. Cocaine subjects will be matched for age and nicotine dependence. Women taking birth control pills, or Depo Provera (medroxyprogesterone acetate) will be excluded from study participation. Subjects will be recruited through the use of flyers, advertisements on the MUSC website, MUSC broadcast messages, advertisement in local newspapers and weeklies, and similar ongoing studies within the Clinical Neuroscience Division. |
Condition ICMJE | Cocaine Dependence |
Intervention ICMJE | Drug: Acthrel
1 ug/kg, i.v., 1 minute |
Study Group/Cohort (s) |
|
Publications * | |
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
Recruitment Information | |
Recruitment Status ICMJE | Completed |
Estimated Enrollment ICMJE | 20 |
Completion Date | January 2011 |
Primary Completion Date | January 2011 (final data collection date for primary outcome measure) |
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
Gender | Both |
Ages | 18 Years to 65 Years |
Accepts Healthy Volunteers | No |
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
Location Countries ICMJE | United States |
Administrative Information | |
NCT Number ICMJE | NCT00756925 |
Other Study ID Numbers ICMJE | HR18441 |
Has Data Monitoring Committee | Yes |
Responsible Party | Megan Moran-Santa Maria, Medical University of South Carolina |
Study Sponsor ICMJE | Medical University of South Carolina |
Collaborators ICMJE | |
Investigators ICMJE | |
Information Provided By | Medical University of South Carolina |
Verification Date | July 2011 |
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |